What topics does this cannabis study cover?

This study covers research on: THC, Mental Health.

Where was this research published?

Published in Neuroscience and biobehavioral reviews on June 3, 2026.

THC Mental Health

Understanding THC's effects: dose matters most for new users

The subjective effects of △9-tetrahydrocannabinol: A systematic review and dose-response meta-regression.

Neuroscience and biobehavioral reviews • June 3, 2026 • Review • Moderately Relevant

🤖

AI Summary

This comprehensive systematic review and meta-analysis examined the subjective effects of THC in 1,020 healthy, infrequent cannabis users across 41 controlled studies. The researchers found that inhaled THC produced predictable dose-dependent effects: at 5mg, users experienced significantly greater feelings of being high (34.3 points on a 100-point scale), increased anxiety (14.4 points), and decreased alertness (40.2 points). Surprisingly, calmness showed no significant difference between THC and placebo overall, though individual doses of 5mg did increase calmness slightly. The findings reveal important variability: higher doses of inhaled THC created more consistent effects between individuals, particularly for the "high" feeling and contentedness, suggesting that stronger products may be more predictable in their impact.

Oral administration of THC presented a very different picture from smoking or vaping. Oral doses showed no clear dose-response relationship with subjective effects in the studies analyzed, though higher doses did produce greater consistency in alertness changes between users. This distinction is crucial for public health, as it indicates that inhaled THC produces more reliable and measurable effects than edibles. The research underscores how potency increases in modern cannabis products could intensify subjective effects—particularly anxiety—among inexperienced users, who may not anticipate the strength of current cannabis strains.

These evidence-based findings provide practical guidance for harm reduction and public health education. The study demonstrates that effects like anxiety and reduced alertness are dose-dependent, meaning that lower doses of inhaled THC may minimize adverse effects for new users. Understanding these relationships is essential as cannabis policies continue to liberalize globally and products become increasingly potent, more accessible, and marketed to less experienced consumers who need clear information about what to expect.

📄 Original Abstract

Global shifts towards the liberalisation of cannabis policies have increased the potency of cannabis products, alongside their accessibility, diversity, and the number of inexperienced cannabis consumers. There is a lack of systematic evidence on the subjective effects of cannabis' main psychoactive compound, Δ9-tetrahydrocannabinol (THC). We systematically reviewed and meta-analysed data from 41 randomised, double-blind, and placebo-controlled experimental studies on the acute subjective effects of THC in 1,020 healthy individuals with infrequent cannabis use (<2 weekly; <100 lifetime). Pairwise meta-analyses estimating the mean difference of peak subjective effects between THC and placebo showed greater feelings of high, anxiety, and tiredness (all p<0.001), lower alertness and contentedness (both p<0.01), and no difference on calmness (p=0.414). Meta-regressions of dose were stratified by inhaled and oral administration. Greater inhaled THC dose increased feeling high (b=1.06, p=0.0024) and contentedness (b=1.06, p=0.025), and decreased calmness (b=-0.96, p=0.048); with no change in anxiety (b=-0.03, p=0.845), tiredness (b=0.39, p=0.129), or alertness (b=0.11, p=0.837). Variability meta-analyses showed that greater inhaled dose of THC produced greater consistency between individuals in feeling high (b=-0.05, p=0.021) and contentedness (b=-0.04, p<0.0001). On a 100-point scale, inhaling 5mg THC resulted in: increased high, anxiety, tiredness, and calmness by 34.3 (95%CI: 30.8-37.7), 14.4 (95%CI: 12.8-16.0), 26.3 (95%CI: 23.8-28.8), 4.5 (95%CI: -0.3-9.3), respectively; decreased alertness and contentedness by 40.2 (95%CI: -45.4--34.9) and 71.0 (95%CI: -75.7--66.4), respectively. Oral dose was not associated with any subjective effects (p>0.05), although variability meta-analyses showed that greater oral dose of THC produced greater consistency between individuals in alertness (b=-0.13, p=0.049). This evidence can inform public health efforts to guide consumers on the expected subjective effects of THC.

Paper Type

📚 Review

Publication

Journal: Neuroscience and biobehavioral reviews
Published: June 3, 2026
PMID: 42242480
DOI: 10.1016/j.neubiorev.2026.106795

Authors (19)

Isabella Goodwin Neuroscience of Addiction and Mental health Program, Healthy Brain and Mind Research Centre, School of Behavioural and Health Sciences, Australian Catholic University, Melbourne, VIC, Australia.
Dominic Oliver Department of Psychiatry, University of Oxford, Oxford, England, UK.
Edward Chesney Institute of Psychiatry, Psychology and Neuroscience, King's College London, England, UK.
Alexandra Gaillard Department of Health Science and Biostatistics, Swinburne University of Technology, Melbourne, VIC, Australia.
Simiao Wang Institute of Psychiatry, Psychology and Neuroscience, King's College London, England, UK.
+14 more authors